Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine

Vaccine

Volumn 23, Issue 28, 2005, Pages 3634-3641

  Nardelli Haefliger, Denise ^a   Lurati, Floriana ^a   Wirthner, Daniel ^a   Spertini, François ^a   Schiller, John T ^b   Lowy, Douglas R ^b   Ponci, Françoise ^a   De Grandi, Pierre ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Aerosol vaccination; Cervical cancer; Human papillomavirus; Virus like particles

Indexed keywords

ACETYLSALICYLIC ACID; HUMAN PAPILLOMAVIRUS TYPE 16 VIRUS LIKE PARTICLE VACCINE; IMMUNOGLOBULIN A; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS VACCINE;

ADULT; ANTIBODY TITER; ARTHRALGIA; ARTICLE; CHILL; CONTROLLED STUDY; COUGHING; DOSE RESPONSE; DRUG FEVER; DRUG TOLERABILITY; DYSPNEA; FATIGUE; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNE RESPONSE; INTERMETHOD COMPARISON; MUCOSAL IMMUNITY; MYALGIA; NASAL PRURITUS; NEBULIZATION; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHARYNX DISEASE; PRIORITY JOURNAL; PRURITUS; RESPIRATORY TRACT MUCOSA; SIDE EFFECT; SNEEZING; SORE THROAT; THROAT; VIRUS INDUCTION; VIRUS PARTICLE;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; AEROSOLS; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INJECTIONS, INTRAMUSCULAR; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; RESPIRATORY MUCOSA; UTERINE CERVICAL NEOPLASMS; VIRAL VACCINES;

EID: 18844377157     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.02.019     Document Type: Article

References (47)

1. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, and K.V. Shah Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1 1999 12 19
2. F.X. Bosch, A. Lorincz, N. Munoz, C.J. Meijer, and K.V. Shah The causal relation between human papillomavirus and cervical cancer J Clin Pathol 55 2002 244 265
3. D. Lowy, and P.M. Howley Papillomaviruses 4th ed. 2001 Lippincott, Williams, Wilkins Philadelphia p. 2231-64
4. J.T. Schiller, and P. Davies Delivering on the promise: HPV vaccines and cervical cancer Nat Rev Microbiol 2 2004 343 347
5. D.R. Lowy, and I.H. Frazer Chapter 16: Prophylactic human papillomavirus vaccines J Natl Cancer Inst Monogr 31 2003 111 116
6. C.D. Harro, Y.Y. Pang, R.B. Roden, A. Hildesheim, Z. Wang, and M.J. Reynolds Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine J Natl Cancer Inst 93 4 2001 284 292
7. T.G. Evans, W. Bonnez, R.C. Rose, S. Koenig, L. Demeter, and J.A. Suzich A phase 1 study of a recombinant virus-like particle vaccine against human papillomavirus type 11 in healthy adult volunteers J Infect Dis 183 2001 1485 1493
8. Brown DR, Bryan JT, Schroeder JM, Robinson TS, Fife KH, Wheeler CM, et al. Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles: Correlation with competitive radioimmunoassay titer. J Infect Dis 2001;184:1183-86.
9. L.A. Koutsky, D.A. Ault, C.M. Wheeler, D.R. Brown, E. Barr, and F.B. Alvarez A controlled trial of a human papillomavirus type 16 vaccine N Engl J Med 347 2002 1645 1651
10. D. Nardelli-Haefliger, D. Wirthner, J.T. Schiller, D.R. Lowy, HildesheimA, and F. Ponci Specific antibody levels at the cervix during the menstrual-cycle of women vaccinated with Human Papillomavirus 16 virus-like particles J Natl Canc Inst 95 2003 1128 1137
11. M. McDermott, and J. Bienenstock Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues J Immunol 122 1979 1892 1898
12. J.P. Bouvet, L. Belec, R. Pires, and J. Pillot Immunoglobulin G antibodies in human vaginal secretions after parenteral vaccination Infect Immun 62 9 1994 3957 3961
13. C. Balmelli, R. Roden, A. Potts, J. Schiller, P. De Grandi, and D. Nardelli-Haefliger Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions J Virol 72 10 1998 8220 8229
14. D. Nardelli-Haefliger, R. Roden, C. Balmelli, A. Potts, J. Schiller, and P. De Grandi Mucosal but not parenteral immunization with purified human papillomavirus type 16 virus-like particles induces neutralizing titers of antibodies throughout the estrous cycle of mice J Virol 74 1999 9609 9613
15. N. Decroix, H. Hocini, C.P. Quan, B. Bellon, M.D. Kazatchkine, and J.-P. Bouvet Induction in mucosa of IgG and IgA antibodies against parenterally administered soluble immunogens Scand J Immunol 53 2001 401 409
16. W.H. Kutteh Ogra Mucosal immunity in the human female reproductive tract 2nd ed. 1999 Academic Press San Diego p. 1423-34
17. J.M. Ellen, C.J. Lammel, M.-A. Shafer, E. Teitle, J. Schachter, and R.S. Stephens Cervical secretory immunogloublin A in adolescent girls J Adolesc Health 25 1999 150 154
18. A. De Haan, K.B. Renegar, P.J. Small, and J. Wilschut Induction of a secretory IgA response in the murine female urogenital tract by immunization of the lungs with liposome-supplemented viral subunit antigen Vaccine 13 7 1995 613 616
19. W.S. Gallichan, and K.L. Rosenthal Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus Vaccine 13 16 1995 1589 1595
20. S. Hopkins, J.-P. Kraehenbuhel, F. Schödel, A. Potts, D. Peterson, and P. De Grandi A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization Infect Immun 63 1995 3279 3286
21. S. Pal, E.M. Peterson, and L.m. de la Maza Intranasal immunization induces long-term protection in mice against a Chlamydia trachomatis genital challenge Infect Immun 64 12 1996 5341 5348
22. A. Di Tommaso, G. Saletti, M. Pizza, R. Rappuoli, G. Dougan, and S. Abrignani Induction of antigen-specific antibodies in vaginal secretions by using a non toxic mutant of heat-labile enterotoxin as a mucosal adjuvant Infect Immun 64 3 1996 974 979
23. M.W. Russell, Z. Moldoveanu, P.L. White, G.J. Sibert, J. Mestecky, and S.M. Michalek Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the cholera toxin b subunit Infect Immun 64 4 1996 1272 1283
24. H.F. Staats, W.G. Nichols, and T.J. Palker Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A) J Immunol 157 1 1996 462 472
25. C. Bergquist, E.L. Johansson, T. Lagergard, J. Holmgren, and A. Rudin Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina Infect Immun 65 7 1997 2676 2684
26. C. Balmelli, S. Demotz, H. Acha-Orbea, P. De Grandi, and D. Nardelli-Haefliger Trachea, lung, and tracheobronchial lymph nodes are the major sites where antigen-presenting cells are detected after nasal vaccination of mice with human papillomavirus type 16 virus-like particles J Virol 76 24 2002 12596 12602
27. C. Czerkinsky, A.-M. Svennerholm, M. Quiding, R. Jonsson, and Holmgren Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans Infect Immun 59 1991 996 1001
28. Roden RBS, H.L. Greenstone, R. Kirnabauer, J.P. Booy, J. Jessie, and D.R. Lowy In vitro Generation and Type-Specific Neutralization of a Human Papillomavirus Type 16 Virion Pseudotype J Virol 70 1996 5875 5883
29. D.V. Pastrana, C.B. Buck, Y.Y. Pang, C.D. Thompson, P.E. Castle, and P.C. FitzGerald Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18 Virol 321 2004 205 216
30. K.H.G. Mils, C. Cosgrove, E.A. McNeela, A. Sexton, R. Giemza, and I. Jabbal-Gill Protective levels of diphteria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin A Infect Immun 71 2003 726 732
31. A.M. Harandi, J. Sanchez, K. Eriksson, and J. Holmgren Recent developments in mucosal immunomodulatory adjuvants Curr Opin Investig Drugs 2 2003 156 161
32. J.B. Ulmer, and M.A. Liu Ethical issues for vaccines and immunization Nature Rev 2 2002 291 296
33. J.-H. Kao, and D.-S. Chen Global control of hepatitis B virus infection Lancet 2 2002 395 403
34. J.P. Hughes, G.P. Garnett, and L.A. Koutsky The theoretical population-level impact of a prophylactic human papillomavirus vaccine Epidemiol 13 2002 631 639
35. J. Mestecky, W.H. Kutteh, and S. Jackson Mucosal immunity in the female genital tract: Relevance to vaccination efforts against the human immunodeficiency virus AIDS Res Hum Retroviruses 10 1994 11 s20
36. A. Phalipon, and B. Corthésy Novel functions of the polymeric Ig receptor: well beyond transport of immunoglobulins Trends Immunol 24 2003 55 58
37. Z. Moldoveanu, M.L. Clements, S.J. Prince, B.R. Murphy, and J. Mestecky Human immune responses to influenza virus vaccines administered by systemic or mucosal routes Vaccine 13 11 1995 1006 1012
38. P.A. Kozlowski, U.S. Cu, M.R. Neutra, and T.P. Flanigan Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women Infect Immun 65 4 1997 1387 1394
39. W.H. Kutteh, A. Kantele, Z. Moldoveanu, P.A. Crowley-Nowick, and J. Mestecky Induction of specific immune responses in the genital tract of women after oral or rectal immunization and rectal boosting with Salmonella typhi Ty 21a vaccine J Reprod Immunol 52 2001 61 75
40. D. Nardellihaefliger, J.P. Kraehenbuhl, R. Curtiss, F. Schodel, A. Potts, and S. Kelly Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain Infect Immun 64 12 1996 5219 5224
41. L. Wassen, K. Schon, J. Holmgren, M. Jertborn, and N. Lycke Local intravaginal vaccination of the female genital tract Scand J Immunol 44 4 1996 408 414
42. P.A. Crowley-Nowick, M.C. Bell, R. Brockwell, R.P. Edwards, S. Chen, and E.E. Partridge Rectal immunization for induction of specific antibody in the genital tract of women J Clin Immunol 17 5 1997 370 379
43. A. Kantele, M. Hakkinen, Z. Moldoveanu, A. Lu, E. Savilahti, and R.D. Alvarez Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: Evidence for compartmentalization within the common mucosal immune system in humans Infect Immun 66 12 1998 5630 5635
44. E.-L. Johansson, L. Wassen, J. Holmgren, M. Jertborn, and R. Rudin Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans Infect Immun 69 2001 7481 7486
45. P.A. Kozlowski, S.B. Williams, R.M. Lynch, T.P. Flanigan, R.R. Patterson, and S. Cu-Uvin Differential induction of mucosal and systemic antibody responses in women after nasal, rectal or vaginal immunization: influence of the menstrual cycle J Immunol 169 2002 566 574
46. A. Dilraj, F.T. Cutts, J.F. De Castro, J.G. Wheeler, D. Brown, and C. Roth Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial Lancet 355 2000 798 803
47. D. LiCalsi, M.J. Maniaci, T. Christensen, E. Phillips, G.H. Ward, and C. Witham Powder formulation of measles vaccine for aerosol delivery Vaccine 19 2001 2629 2636